OZAWAVE Trademark

Trademark Overview

On Monday, January 6, 2020, a trademark application was filed for OZAWAVE with the United States Patent and Trademark Office. The USPTO has given the OZAWAVE trademark a serial number of 79279534. The federal status of this trademark filing is REGISTERED as of Tuesday, September 1, 2020. This trademark is owned by BIOPROJET EUROPE LIMITED. The OZAWAVE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products for treating respiratory diseases
ozawave

General Information

Serial Number79279534
Word MarkOZAWAVE
Filing DateMonday, January 6, 2020
Status700 - REGISTERED
Status DateTuesday, September 1, 2020
Registration Number6138800
Registration DateTuesday, September 1, 2020
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 16, 2020

Trademark Statements

Goods and ServicesPharmaceutical products for treating respiratory diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, February 28, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBIOPROJET EUROPE LIMITED
Party Type30 - Original Registrant
Legal Entity Type11 - Company
AddressIE
Party NameBIOPROJET EUROPE LIMITED
Party Type20 - Owner at Publication
Legal Entity Type11 - Company
AddressIE
Party NameBIOPROJET EUROPE LIMITED
Party Type10 - Original Applicant
Legal Entity Type11 - Company
AddressIE

Trademark Events

Event DateEvent Description
Wednesday, March 25, 2020ASSIGNED TO EXAMINER
Thursday, February 27, 2020SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, February 28, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, March 3, 2020APPLICATION FILING RECEIPT MAILED
Wednesday, April 1, 2020NON-FINAL ACTION WRITTEN
Thursday, April 2, 2020NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, April 17, 2020REFUSAL PROCESSED BY MPU
Friday, April 17, 2020NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, April 27, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, April 27, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, April 27, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, April 28, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, May 7, 2020ASSIGNED TO LIE
Friday, May 8, 2020REFUSAL PROCESSED BY IB
Tuesday, June 16, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, May 27, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 16, 2020PUBLISHED FOR OPPOSITION
Tuesday, September 1, 2020REGISTERED-PRINCIPAL REGISTER
Saturday, December 19, 2020GENERIC MADRID TRANSACTION CREATED
Tuesday, December 1, 2020FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Friday, August 30, 2024NEW REPRESENTATIVE AT IB RECEIVED
Saturday, January 30, 2021FINAL DECISION TRANSACTION PROCESSED BY IB
Saturday, December 19, 2020GENERIC MADRID TRANSACTION SENT TO IB

Related Keywords

ozawave diseases respiratory treating products pharmaceutical